FI954386A0 - (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö - Google Patents
(1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttöInfo
- Publication number
- FI954386A0 FI954386A0 FI954386A FI954386A FI954386A0 FI 954386 A0 FI954386 A0 FI 954386A0 FI 954386 A FI954386 A FI 954386A FI 954386 A FI954386 A FI 954386A FI 954386 A0 FI954386 A0 FI 954386A0
- Authority
- FI
- Finland
- Prior art keywords
- triazolo
- preparation
- quinoxaline derivative
- quinoxaline
- derivative
- Prior art date
Links
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK93310A DK31093D0 (zh) | 1993-03-19 | 1993-03-19 | |
PCT/DK1994/000077 WO1994021639A1 (en) | 1993-03-19 | 1994-02-25 | [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954386A0 true FI954386A0 (fi) | 1995-09-18 |
FI954386A FI954386A (fi) | 1995-09-18 |
Family
ID=8092112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954386A FI954386A (fi) | 1993-03-19 | 1995-09-18 | (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö |
Country Status (16)
Country | Link |
---|---|
US (1) | US5559106A (zh) |
EP (1) | EP0691969A1 (zh) |
JP (1) | JPH08507536A (zh) |
KR (1) | KR100313051B1 (zh) |
CN (1) | CN1041930C (zh) |
AU (1) | AU685783B2 (zh) |
CA (1) | CA2158545A1 (zh) |
DK (1) | DK31093D0 (zh) |
FI (1) | FI954386A (zh) |
HU (1) | HUT73419A (zh) |
IL (1) | IL108800A (zh) |
NO (1) | NO305286B1 (zh) |
NZ (1) | NZ262365A (zh) |
TW (1) | TW304195B (zh) |
WO (1) | WO1994021639A1 (zh) |
ZA (1) | ZA941926B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4314592A1 (de) * | 1993-04-28 | 1994-11-03 | Schering Ag | Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
DK0781282T3 (da) * | 1994-09-16 | 2000-02-28 | Novo Nordisk As | [1,2]triazolo[4,3-a]quinoxalinonderivater, deres fremstilling og anvendelse |
HUT76810A (en) * | 1994-09-16 | 1997-11-28 | Novo Nordisk As | [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, process for their preparation and pharmaceutical compositions containing them |
US5679680A (en) * | 1995-02-16 | 1997-10-21 | Warner-Lambert Company | α-substituted hydrazides having calpain inhibitory activity |
FR2743363A1 (fr) * | 1996-01-10 | 1997-07-11 | Rhone Poulenc Rorer Sa | 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
TR200001728T2 (tr) | 1997-11-11 | 2000-09-21 | Ono Pharmaceutical Co., Ltd. | Birleşik pirazin türevleri |
WO1999040063A1 (fr) * | 1998-02-06 | 1999-08-12 | Yoshitomi Pharmaceutical Industries, Ltd. | Nouveaux derives de l'acide hydroxamique de type azapeptide |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
CN101553491B (zh) * | 2006-12-13 | 2013-05-29 | Aska制药株式会社 | 喹喔啉衍生物 |
RU2011140333A (ru) | 2009-03-05 | 2013-04-10 | Астеллас Фарма Инк. | Хиноксалиновое соединение |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
ES2747423T3 (es) * | 2010-09-07 | 2020-03-10 | Astellas Pharma Inc | Compuesto de quinoxalina |
WO2013000924A1 (en) | 2011-06-27 | 2013-01-03 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
US9669035B2 (en) | 2012-06-26 | 2017-06-06 | Janssen Pharmaceutica Nv | Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4354027A (en) * | 1980-05-19 | 1982-10-12 | Usv Pharmaceutical Corporation | Triazoloquinoxalin-4-ones |
US4547501A (en) * | 1983-09-02 | 1985-10-15 | Pfizer Inc. | Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents |
US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
AU3767793A (en) * | 1992-04-03 | 1993-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
-
1993
- 1993-03-19 DK DK93310A patent/DK31093D0/da not_active Application Discontinuation
-
1994
- 1994-02-25 HU HU9502726A patent/HUT73419A/hu unknown
- 1994-02-25 KR KR1019950703970A patent/KR100313051B1/ko not_active IP Right Cessation
- 1994-02-25 NZ NZ262365A patent/NZ262365A/en unknown
- 1994-02-25 WO PCT/DK1994/000077 patent/WO1994021639A1/en not_active Application Discontinuation
- 1994-02-25 CN CN94191979A patent/CN1041930C/zh not_active Expired - Fee Related
- 1994-02-25 CA CA002158545A patent/CA2158545A1/en not_active Abandoned
- 1994-02-25 AU AU62018/94A patent/AU685783B2/en not_active Ceased
- 1994-02-25 JP JP6520538A patent/JPH08507536A/ja active Pending
- 1994-02-25 EP EP94908979A patent/EP0691969A1/en not_active Withdrawn
- 1994-02-28 TW TW083101703A patent/TW304195B/zh active
- 1994-03-01 IL IL108800A patent/IL108800A/en active IP Right Grant
- 1994-03-18 ZA ZA941926A patent/ZA941926B/xx unknown
- 1994-12-07 US US08/350,744 patent/US5559106A/en not_active Expired - Fee Related
-
1995
- 1995-09-18 NO NO953673A patent/NO305286B1/no not_active IP Right Cessation
- 1995-09-18 FI FI954386A patent/FI954386A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
IL108800A (en) | 1998-02-22 |
HUT73419A (en) | 1996-07-29 |
EP0691969A1 (en) | 1996-01-17 |
NO953673D0 (no) | 1995-09-18 |
CN1122601A (zh) | 1996-05-15 |
DK31093D0 (zh) | 1993-03-19 |
US5559106A (en) | 1996-09-24 |
JPH08507536A (ja) | 1996-08-13 |
IL108800A0 (en) | 1994-06-24 |
FI954386A (fi) | 1995-09-18 |
AU685783B2 (en) | 1998-01-29 |
CN1041930C (zh) | 1999-02-03 |
NO953673L (no) | 1995-11-17 |
HU9502726D0 (en) | 1995-11-28 |
CA2158545A1 (en) | 1994-09-29 |
KR100313051B1 (ko) | 2002-02-28 |
NZ262365A (en) | 1997-05-26 |
AU6201894A (en) | 1994-10-11 |
TW304195B (zh) | 1997-05-01 |
NO305286B1 (no) | 1999-05-03 |
ZA941926B (en) | 1995-09-18 |
WO1994021639A1 (en) | 1994-09-29 |
KR960701057A (ko) | 1996-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961219A0 (fi) | Kemialliset yhdisteet, niiden valmistus ja käyttö | |
IL92213A0 (en) | Foldable chair | |
IL111526A0 (en) | 7H-imidazo (1,2-a) pyrazin-8-one derivatives and their preparation and use | |
GB2235623B (en) | Foldable playyard | |
IL118812A0 (en) | Poly (arylene ether) compounds their preparation and use | |
DE69529777D1 (de) | 2-Benzylthio-8-amino(1,2,4)triazolo(1,5-a)pyridine | |
NZ232168A (en) | Perhydropyrido(1,2-a)pyrazine derivatives; intermediates and pharmaceutical compositions | |
ITMI922995A0 (it) | Granulati di coloranti scorrevoli chimicamente resistenti loro preparazione e loro impiego | |
FR2744442B1 (fr) | Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane | |
FI954386A (fi) | (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö | |
NO974150D0 (no) | 6-arylpyrazolo(3,4-d)pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav | |
FI101382B1 (fi) | Dihydroksipropyylisulfoetyyliselluloosia, niiden valmistus ja käyttö | |
FI923290A (fi) | Imidazo(2,1-b)bensotiazol-3-acetamidderivat | |
EP0511152A3 (en) | Quinoxaline compounds, their preparation and use | |
FI942468A0 (fi) | Kemialliset yhdisteet, niiden valmistus ja käyttö | |
ZA926132B (en) | New pyrazine derivatives,the preparation and use thereof | |
ITMI912290A0 (it) | Miscele di n-alchilftalimmidi, loro preparazione e loro impiego | |
EP0442086A3 (en) | Graftcopolymers, their preparation and their use | |
GB9001148D0 (en) | Foldable chair | |
BR9106372A (pt) | Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico | |
ITMI931897A0 (it) | 1,3,4- benzotriazepin-554h)-one e procedimento per la loro preparazione | |
FI935915A (fi) | 2-tienyyli-imidatso(2,1-b)bentsotiatsol-3-etikkahappojohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
FI973631A (fi) | 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö | |
NO170620C (no) | Trinse | |
DK88093D0 (da) | Stabilt praeparat |